Alnylam Pharmaceuticals (ALNY) Q3 2019 Earnings

6AugConfirmed
Q4 2018
Q1 2019
Q2 2019
Q3 2019
-2.43
-2.2
-1.96
-1.73

Details

Expected EPS
-2.02
Actual EPS
-1.93
Surprise EPS
0.09
Surprise Percent
+4.46%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.93 per share for Q3 2019.

0 Comments

Share your thoughts